Full Text
The Full Text of this article is available as a PDF (60.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baron T. H., Truss C. D., Elson C. O. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci. 1993 Oct;38(10):1851–1856. doi: 10.1007/BF01296109. [DOI] [PubMed] [Google Scholar]
- Feagan B. G., Fedorak R. N., Irvine E. J., Wild G., Sutherland L., Steinhart A. H., Greenberg G. R., Koval J., Wong C. J., Hopkins M. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000 Jun 1;342(22):1627–1632. doi: 10.1056/NEJM200006013422202. [DOI] [PubMed] [Google Scholar]
- Feagan B. G., Rochon J., Fedorak R. N., Irvine E. J., Wild G., Sutherland L., Steinhart A. H., Greenberg G. R., Gillies R., Hopkins M. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995 Feb 2;332(5):292–297. doi: 10.1056/NEJM199502023320503. [DOI] [PubMed] [Google Scholar]
- Hamilton R. A., Kremer J. M. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):86–90. doi: 10.1093/rheumatology/36.1.86. [DOI] [PubMed] [Google Scholar]
- Kozarek R. A., Patterson D. J., Gelfand M. D., Botoman V. A., Ball T. J., Wilske K. R. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989 Mar 1;110(5):353–356. doi: 10.7326/0003-4819-110-5-353. [DOI] [PubMed] [Google Scholar]
- Lémann M., Zenjari T., Bouhnik Y., Cosnes J., Mesnard B., Rambaud J. C., Modigliani R., Cortot A., Colombel J. F. Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol. 2000 Jul;95(7):1730–1734. doi: 10.1111/j.1572-0241.2000.02190.x. [DOI] [PubMed] [Google Scholar]
- Moshkowitz M., Oren R., Tishler M., Konikoff F. M., Graff E., Brill S., Yaron M., Gilat T. The absorption of low-dose methotrexate in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 1997 Jun;11(3):569–573. doi: 10.1046/j.1365-2036.1997.00175.x. [DOI] [PubMed] [Google Scholar]
- Tang H., Neuberger J. Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood? Aliment Pharmacol Ther. 1996 Dec;10(6):851–858. doi: 10.1046/j.1365-2036.1996.70244000.x. [DOI] [PubMed] [Google Scholar]
- Te H. S., Schiano T. D., Kuan S. F., Hanauer S. B., Conjeevaram H. S., Baker A. L. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000 Nov;95(11):3150–3156. doi: 10.1111/j.1572-0241.2000.03287.x. [DOI] [PubMed] [Google Scholar]